期刊文献+

盐酸维拉佐酮的合成工艺研究 被引量:1

Synthesis of vilazodone hydrochloride
原文传递
导出
摘要 目的对盐酸维拉佐酮的合成工艺进行研究。方法以5-氰基吲哚为起始原料,通过傅克反应、还原反应、磺酰化反应、缩合反应得到维拉佐酮,然后与盐酸反应得到盐酸维拉佐酮。结果合成了目标化合物,并利用1H-NMR、MS确证了结构。此路线的总收率为47.89%,质量分数为99.66%。结论该合成工艺设计合理,操作简单,适用于工业化生产,盐酸维拉佐酮的收率和纯度较高。 Objective To study the synthetic technology of vilazodone hydrochloride. Methods 5-Cyanoindole was used as starting material to synthesize vilazodone by Friedel-Craft reaction, reduction reaction, sulfonylation reaction, and condensation reaction. Then vilazodone hydrochloride was synthesized by reacting with hydrochloric acid. Results The target compound was synthesized and characterized by 1H-NMR and MS. The total yield of vilazodone hydrochloride with the purity of 99.66% was 47.89%. Conclusion The synthetic route of vilazodone hydrochloride has the advantages of reasonable design and simple operation with high yield and purity, and is suitable for industrial production.
出处 《现代药物与临床》 CAS 2015年第7期753-756,共4页 Drugs & Clinic
关键词 盐酸维拉佐酮 5-氰基吲哚 合成 vilazodone hydrochloride 5-cyanoindole synthesis
  • 相关文献

参考文献9

二级参考文献29

  • 1KHAN A. Vilazodone, a novel dual-acting serotonergic antidepres- sant for managing major depression [ J ]. Expert Opin lnvestig Drugs, 2009,18 ( 11 ) : 1753 - 1764.
  • 2HOWLAND RH. Vilazodone: another novel atypical antidepres- sant drug[ J ] . J Psychosoc Nurs Ment Health Serv , 2011,49 ( 3 ) : 19 -22.
  • 3DAWSON LA, WATSON JM. Vilazodone: a 5-HT1A receptor ago- nist/serotonin transporter inhibitor for the treatment of affective disorders [ J ]. CNS Neurosci Ther ,2009 ,15 (2) : 107 - 117.
  • 4DE PAULIS T. Drug evaluation: vilazodone- a combined SSRI and 5-HT1A partial agonist for the treatment of depression [ J]. Drugs,2007,10 ( 3 ) : 193 - 201.
  • 5ROBERTS C, HAGAN JJ, BARTOSZYK GD, et al. Effect of vilazodonc on 5-HT efflux and re-uptake in the guinea-pig dorsal raphc nucleus [ J ]. Eur J Pharmacol,2005,517 ( 1 - 2 ) : 59 - 63.
  • 6HUGHES ZA, STARR KR, LANGMEAD C J, et al. Neurochemi- cal evaluation of the novel 5-HT1A receptor partial agonist/seroto- nin reuptake inhibitor, vilazodone [ J ]. Eur J Pharmacol, 2005, 510(1 -2) :49 -57.
  • 7Vilazodone [ EB/OL ]. [ 2011 - 05 - 20 ]. http ://www. accessda-ta. fda. gov/drugsatfda docs/label/20! 1/022567s0001b1. pdf.
  • 8RICKELS K, ATHANASIOU M, ROBINSON DS,et al. Evidenee for efficacy and tolerability of vilazodone in the treatment of major depressive disorder: a randomized, double-blind, placebo-con- trolled trial[ J ]. J Clin Psychiatry, 2009,70 ( 3 ) : 326 - 333.
  • 9KHAN A, CUTLER AJ, KAJDASZ DK, et al. A randomized, double-blind, plaeebo-controlled, 8-week study of vilazodone, a serotonergic agent for the treatment of major depressive disorder [J]. J Clin Psyehiatry,2011,72(4):441 -447.
  • 10BOETTCHER H, SEYFRIED C, BARTOSZYK G, et al. Preparation of (indolylalkyl)piperidines and -piperazines as drugs: DE,4333254 [ P ]. 1995 - 04 - 06.

共引文献9

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部